Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

AVLN

Avalyn Pharma Inc

29.59

Aug 04 • 10:02 AM ET +1.09 (3.83%)

Healthcare Biotechnology USA Small NASD

Peers: AAPG ABEO SPTX ABCL ABSI AARD ABOS ABVX ACET IVA

| Held by: VTI IWM VXF VTWO IWO SCHA TMSL IWN VTWG SCHB

Scroll to Statements

Index	RUT
Market Cap	1.31B
Enterprise Value	1.58B
Income	-
Sales	-
Book/sh	-5.96
Cash/sh	2.78
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	50
IPO	Apr 30, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	10.65
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	10.80
Current Ratio	10.80
Debt/Eq	0.15
LT Debt/Eq	0.15
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.42
EPS next Q	-0.76
EPS this Y	26.66%
EPS next Y	12.66%
EPS next 5Y	7.75%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Jun 03 BMO
EPS/Sales Surpr.	-265.25% -

Insider Own	40.04%
Insider Trans	8.49%
Inst Own	5.87%
Inst Trans	85.47%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	4.35%
SMA50	3.08%
SMA200	3.06%
Trades

Shs Outstand	44.33M
Shs Float	26.58M
Short Float	8.24%
Short Ratio	6.06
Short Interest	2.19M
52W High	33.32 -11.19%
52W Low	24.15 22.54%
Volatility	5.75% 6.93%
ATR (14)	2.06
RSI (14)	53.98
Beta	-
Rel Volume	0.21
Avg Volume	361.63K
Volume	9,853

Perf Week	6.49%
Perf Month	7.03%
Perf Quarter	1.80%
Perf Half Y	-
Perf YTD	13.82%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	59.00
Prev Close	28.50
Price	29.59
Change	3.83%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)